786 related articles for article (PubMed ID: 27320173)
21. Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients.
Toth PP; Philip S; Hull M; Granowitz C
Mayo Clin Proc; 2019 Sep; 94(9):1670-1680. PubMed ID: 31405751
[TBL] [Abstract][Full Text] [Related]
22. High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
Omote K; Yokota I; Nagai T; Sakuma I; Nakagawa Y; Kamiya K; Iwata H; Miyauchi K; Ozaki Y; Hibi K; Hiro T; Fukumoto Y; Mori H; Hokimoto S; Ohashi Y; Ohtsu H; Ogawa H; Daida H; Iimuro S; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R; Anzai T
J Atheroscler Thromb; 2022 Jan; 29(1):50-68. PubMed ID: 33431716
[TBL] [Abstract][Full Text] [Related]
23. Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease.
Kou M; Ding N; Ballew SH; Salameh MJ; Martin SS; Selvin E; Heiss G; Ballantyne CM; Matsushita K; Hoogeveen RC
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1229-1238. PubMed ID: 33504178
[TBL] [Abstract][Full Text] [Related]
24. High density lipoprotein cholesterol subfractions in older people.
Ettinger WH; Verdery RB; Wahl PW; Fried LP
J Gerontol; 1994 May; 49(3):M116-22. PubMed ID: 8169333
[TBL] [Abstract][Full Text] [Related]
25. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.
Pfeffer MA; Sacks FM; Moyé LA; East C; Goldman S; Nash DT; Rouleau JR; Rouleau JL; Sussex BA; Theroux P; Vanden Belt RJ; Braunwald E
J Am Coll Cardiol; 1999 Jan; 33(1):125-30. PubMed ID: 9935018
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of simvastatin and lovastatin/extended- release niacin to achieve LDL and HDL goal using NHANES data.
Armstrong EP; Zachry WM; Malone DC
J Manag Care Pharm; 2004; 10(3):251-8. PubMed ID: 15228376
[TBL] [Abstract][Full Text] [Related]
27. Administration of eicosapentaenoic acid may alter high-density lipoprotein heterogeneity in statin-treated patients with stable coronary artery disease: A 6-month randomized trial.
Tani S; Matsuo R; Yagi T; Matsumoto N
J Cardiol; 2020 Mar; 75(3):282-288. PubMed ID: 31543378
[TBL] [Abstract][Full Text] [Related]
28. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects.
Ballantyne FC; Clark RS; Simpson HS; Ballantyne D
Metabolism; 1982 May; 31(5):433-7. PubMed ID: 6952064
[TBL] [Abstract][Full Text] [Related]
29. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
[TBL] [Abstract][Full Text] [Related]
30. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.
Olsson AG; Schwartz GG; Szarek M; Sasiela WJ; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A
Eur Heart J; 2005 May; 26(9):890-6. PubMed ID: 15764620
[TBL] [Abstract][Full Text] [Related]
31. Circadian Rhythm of Subspecies of Low-Density Lipoprotein-Cholesterol and High-Density Lipoprotein-Cholesterol in Healthy Subjects and Patients with Type 2 Diabetes.
Hayashi T; Ai M; Goto S; Nakamura M; Nagaike H; Suzuki R; Abe Y; Ohta M; Ito Y; Hirano T
J Atheroscler Thromb; 2023 Jan; 30(1):3-14. PubMed ID: 35249932
[TBL] [Abstract][Full Text] [Related]
32. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
[TBL] [Abstract][Full Text] [Related]
33. Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease.
Superko HR; Haskell WL; Krauss RM
Atherosclerosis; 1993 Jun; 101(1):1-8. PubMed ID: 8105786
[TBL] [Abstract][Full Text] [Related]
34. Triglyceride and Triglyceride/ HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease.
Prasad M; Sara J; Widmer RJ; Lennon R; Lerman LO; Lerman A
J Am Heart Assoc; 2019 May; 8(9):e009442. PubMed ID: 31014162
[TBL] [Abstract][Full Text] [Related]
35. High-density Lipoprotein-cholesterol Subfractions and Coronary Artery Calcium: The ELSA-Brasil Study.
Generoso G; Bensenor IM; Santos RD; Staniak HL; Sharovsky R; Santos IS; Goulart AC; Jones SR; Kulkarni KR; Blaha MJ; Toth PP; Lotufo PA; Bittencourt MS
Arch Med Res; 2019 Aug; 50(6):362-367. PubMed ID: 31678894
[TBL] [Abstract][Full Text] [Related]
36. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.
Simon TG; Corey KE; Cannon CP; Blazing M; Park JG; O'Donoghue ML; Chung RT; Giugliano RP
Int J Cardiol; 2018 Nov; 270():245-252. PubMed ID: 29903515
[TBL] [Abstract][Full Text] [Related]
37. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
Suzuki K; Oikawa T; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Takahashi J; Miyata S; Sakata Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):934-944. PubMed ID: 30866657
[TBL] [Abstract][Full Text] [Related]
38. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Giugliano RP; Cannon CP; Blazing MA; Nicolau JC; Corbalán R; Špinar J; Park JG; White JA; Bohula EA; Braunwald E;
Circulation; 2018 Apr; 137(15):1571-1582. PubMed ID: 29263150
[TBL] [Abstract][Full Text] [Related]
39. The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses.
Moriyama K
Intern Med; 2020 Nov; 59(21):2661-2669. PubMed ID: 32669498
[TBL] [Abstract][Full Text] [Related]
40. Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study.
Tani S; Yagi T; Matsuo R; Kawauchi K; Atsumi W; Matsumoto N; Okumura Y
J Cardiol; 2020 Nov; 76(5):487-498. PubMed ID: 32636128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
